Rocket One/$RKTO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Rocket One

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

Ticker

$RKTO
Sector
Health
Primary listing
NASDAQ

Employees

3
Headquarters
Hoboken, United States
Website
hoththerapeutics.com

Rocket One Metrics

BasicAdvanced
$26m
-
-$0.80
-
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RKTO

Sign up or log in to buy
Capital at risk
Market closedLow-cap

Upcoming events

No upcoming events
FAQs